Canaccord Genuity Raises Price Target on BioMarin Pharma (BMRN) Following BMN-111 Data
Go back to Canaccord Genuity Raises Price Target on BioMarin Pharma (BMRN) Following BMN-111 Data| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 63.94 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $63.94 | 52 Week High | $108.96 | |||
| Open | $63.94 | 52 Week Low | $62.12 | |||
| Day High | $63.94 | P/E | N/A | |||
| Day Low | $63.94 | EPS | $-1.27 | |||
| Volume | 8,504 | |||||
